7 completed, 1 terminated, 1 unknown. 3 Phase 2, 2 Phase 1, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow Fluphenazine: new trials by email Literature Review of Fluphenazine trials Research Report on Fluphenazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Caregiver psycho-education and skills training, Caregiver support available at the study site, Paliperidone palmitate - Schizophrenia | Completed | Janssen Scientific Affairs, LLC | 296 | 2015-07-24 | 2019-01-23 | |
| Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features | Phase 4 | Completed | Technical University of Munich | 21 | 2015-02-01 | 2018-10-11 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Antipsychotics and Risk of Hyperglycemic Emergencies Olanzapine, Risperidone, atypical antipsychotics (other) - Psychotic Disorders, Schizophrenia | Completed | Canadian Network for Observational Drug Effect Studies, CNODES | 725489 | 2012-04-01 | 2015-10-21 | |
| D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement Haloperidol, Fluphenazine, Dexedrine - Pathological Gambling | Phase 2 | Completed | Centre for Addiction and Mental Health | 60 | 2009-09-01 | 2016-04-25 |
| Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma Fluphenazine HCl - Multiple Myeloma | Phase 1 | Unknown | Immune Control | 30 | 2008-12-01 | 2009-01-13 |
| Fluphenazine Hydrochloride for Psoriasis Fluphenazine, Placebo - Psoriasis | Phase 2 | Completed | Tufts Medical Center | 15 | 2008-11-01 | 2017-03-31 |
| Fluphenazine in Treating Patients With Refractory Advanced Multiple Myeloma fluphenazine hydrochloride - Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | Completed | Immune Control | 30 | 2006-01-01 | 2013-11-06 |
| New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia Quetiapine, Risperidone, Fluphenazine - Schizophrenia | Phase 3 | Completed | University of Maryland, Baltimore | 150 | 2003-11-01 | 2019-08-19 |
Schizophrenia (5) · Multiple Myeloma (2) · Psychotic Disorders (2) · Anxiety Disorders (1) · Bipolar Disorder (1) · Dementia (1) · Depression (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Drug-Related Side Effects and Adverse Reactions (1) · Gambling (1) · Neoplasms, Plasma Cell (1) · Psoriasis (1) · Psychophysiologic Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1)
Immune Control (2) · Canadian Network for Observational Drug Effect Studies, CNODES (1) · Centre for Addiction and Mental Health (1) · Hannover Medical School (1) · Janssen Scientific Affairs, LLC (1) · Technical University of Munich (1) · Tufts Medical Center (1) · University of Maryland, Baltimore (1)
United States (5) · Canada (2) · Germany (2)
Alice B. Gottlieb, M.D., PhD. (1) · Bruce A Silver, M.D., FACP (1) · Daniela Lobo, MD, Ph.D. (1) · Helge Frieling, Prof., MD (1) · Lorraine Lipscombe, MD, MSc (1) · Markus Dold, MD (1) · Robert R Conley, MD (1) · Stefan Leucht, Professor (1)